| 000 | 03359cam a2200457 i 4500 | ||
|---|---|---|---|
| 001 | 22133328 | ||
| 003 | KENaKMTC | ||
| 005 | 20251208072540.0 | ||
| 008 | 210714t20192019moua b 001 0 eng c | ||
| 010 | _a 2021301554 | ||
| 016 | 7 |
_a101733002 _2DNLM |
|
| 020 |
_a9780323554299 _q(paperback) |
||
| 020 |
_a0323554296 _q(paperback) |
||
| 035 | _a(OCoLC)on1007052606 | ||
| 040 |
_aNLM _beng _cDLC _erda _dYDX _dOCLCF _dEAU _dOCLCO _dOCLCA _dDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRC388.5 _b.s827 2019 |
| 060 | 0 | 0 | _a2018 G-722 |
| 060 | 1 | 0 | _aWL 356 |
| 100 |
_aFlaker Greg _eEditor |
||
| 130 | 0 | _aStroke prevention in atrial fibrillation (Flaker) | |
| 245 | 1 | 0 |
_aStroke prevention in atrial fibrillation / _c[edited by] Greg Flaker. |
| 260 |
_aSt Louis, Missouri, _bElsevier, _cc2019. |
||
| 300 |
_aix, 192 pages : _billustrations (some color) ; _c23 cm |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _a1. An Economic Analysis of Stroke and Atrial Fibrillation / Arnold J. Greenspon, MD -- 2. Pharmacology of Oral Anticoagulants / Paul P. Dobesh, PharmD, FCCP, BCPS and Zachary A. Stacy, PharmD, FCCP, BCPS -- 3. Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation / David A. Manly, MD and Christopher B. Granger, MD -- 4. Risk Stratification in Atrial Fibrillation / Farhan Shahid, MBBS, BSc, Mikhail Dzeshka, MD, Eduard Shantsila, MD, PhD and Gregory Y.H. Lip, MD, FRCP, FACC, FESC -- 5. Subclinical Atrial Fibrillation: Definition, Prevalence, and Treatment Strategies / Abhinav Sharma, MD, FRCPC and Renato D. Lopes, MD, MHS, PhD -- 6. The New Anticoagulation Clinic / Anne E. Rose, PharmD -- 7. Management of Bleeding Associated With Anticoagulation / Geno J. Merli, MD, MACP, FSVM, FHM and Lynda Thomson, PharmD -- 8. Periprocedural Management of Anticoagulation in Patients With Atrial Fibrillation / Richard Weachter, MD and Greg Flaker, MD -- 9. Special Situations: Anticoagulation for Cardioversion / Chad Ward, MD and Michael C. Giudici, MD, FACC, FACP, FHRS -- 10. Anticoagulation for Ablation Procedures / Michael C. Giudici, MD, FACC, FACP, FHRS and Bria Giacomino, DO -- 11. Surgical and Implanted Devices for the Left Atrial Appendage / Sandeep Gautam, MD, MPH and Joshua Payne, MD, MPH -- 12. Patients Taking Oral Anticoagulants for Atrial Fibrillation With Concomitant Complex Disease States / William J. Hucker, MD, PhD, Mitul Kanzaria, MD, and John U. Doherty, MD, FACC -- 13. Stroke and Atrial Fibrillation: The Neurologist's Perspective / Luciana Catanese, MD and Robert G. Hart, MD -- 14. Stroke and Atrial Fibrillation in Chronic Kidney Disease and Dialysis / David Collister, MD and Michael Walsh, MD, PhD. | |
| 650 | 0 |
_aCerebrovascular disease _xPrevention. |
|
| 650 | 0 | _aAtrial fibrillation. | |
| 650 | 1 | 2 |
_aStroke _xprevention & control. |
| 650 | 1 | 2 |
_aStroke _xetiology. |
| 650 | 2 | 2 |
_aAtrial Fibrillation _xcomplications. |
| 650 | 2 | 2 | _aRisk Factors. |
| 650 | 2 | 2 |
_aStroke _xdrug therapy. |
| 650 | 2 | 2 |
_aAnticoagulants _xtherapeutic use. |
| 650 | 7 |
_aAtrial fibrillation. _2fast |
|
| 650 | 7 |
_aCerebrovascular disease _xPrevention. _2fast |
|
| 700 | 1 |
_aFlaker, Gregory C., _eeditor. |
|
| 906 |
_a7 _bcbc _cpccadap _d2 _encip _f20 _gy-gencatlg |
||
| 942 |
_2lcc _cBK _xBSA |
||
| 999 |
_c46794 _d46794 |
||